The utility of mesoporous silica particles to encapsulate nutraceuticals and thereby serve as a molecular tracker, a drug carrier and a controlled drug release system is investigated.
No takes yet. Share an insight, caveat, or question.
Clifford et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: